News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rothera Mark
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/17/2023 |
4
| Rothera Mark (President and CEO) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 400,000 options to buy
@ $1.65, valued at
$660k
|
|
| 09/19/2022 |
4
| Rothera Mark (President and CEO) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 1,375,000 options to buy
@ $5.21, valued at
$7.2M
|
|
| 05/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/17/2017 |
4
| Rothera Mark (Chief Commercial Officer) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Exercised 2,966 options to buy
@ $10.85, valued at
$32.2k
|
|
| 02/17/2017 |
4
| Rothera Mark (Chief Commercial Officer) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Exercised 3,125 options to buy
@ $10.85, valued at
$33.9k
|
|
| 01/17/2017 |
4
| Rothera Mark (Chief Commercial Officer) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Exercised 3,125 options to buy
@ $10.85, valued at
$33.9k
|
|
| 01/05/2017 |
4
| Rothera Mark (Chief Commercial Officer) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 9,600 shares
@ $0
Granted 56,000 options to buy
@ $11.23, valued at
$628.9k
|
|
| 11/14/2016 |
4
| Rothera Mark (Chief Commercial Officer) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Exercised 1,941 options to buy
@ $10.85, valued at
$21.1k
|
|
| 10/11/2016 |
4
| Rothera Mark (Chief Commercial Officer) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Exercised 1,950 options to buy
@ $10.85, valued at
$21.2k
|
|
| 03/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/27/2013 |
4
| Rothera Mark (Chief Commercial Officer) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Bought 25,000 shares
@ $15, valued at
$375k
Bought 15,000 options to buy
@ $10.85, valued at
$162.8k
Bought 150,000 options to buy
@ $10.85, valued at
$1.6M
|
|
| 06/05/2012 |
4
| Rothera Mark (Global President) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Granted 200,000 options to buy
@ $0
Granted 21,658 options to buy
@ $0 |
|
|
|